Blog
Category: Commercial Scale

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Blog

Genentech, Takeda, Adaptimmune and other industry leaders join Vineti to form the core of this strategic collaboration. The group is...

Repost: a modern patient ID for personalized medicine

Blog

Today, Vineti released an announcement about new industry collaboration around our proposal for a new patient ID for cell and gene therapies....

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Blog

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...

The Vineti Alliance Network — a preview of what’s next

Blog

For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...

How PTM® Label Printing keeps every patient journey on track

Blog

In advanced therapies, little labels — the in-process labels on bags of cells and final drug products — can sometimes...

A true platform is the engine for advanced therapies

Blog

A Vineti technology perspective from Chief Technology Officer Phil Calvin Phil Calvin, Vineti’s Chief Technology Officer, is a long-time leader...

How digital solutions solve the “3D chess game” and drive Commercial success

Blog

A Vineti technology perspective from Chief Commercial Officer Joe DePinto Joe DePinto, Vineti’s Chief Commercial Officer, is a long-time leader...

A modern patient ID for personalized medicine

Blog

Patient-specific therapeutics must be delivered to the patient they are intended to treat. That concept is easy to say —...

Now is the time for proven technology that drives scale

Blog

A Vineti technology perspective from CEO and Co-founder Amy DuRoss   The underlying medical science behind cell and gene therapies continues...

OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies

Blog

Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer...

Vineti Announces New Chief Commercial Officer

Blog

Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...

Q&A: five questions for Joe DePinto

Blog

Today, Vineti is thrilled to announce that Joe DePinto has joined us as our Chief Commercial Officer. Joe is a long-time leader in...